Hutchmed concludes enrolment in Phase II trial of fanregratinib for IHCC
Hutchmed has concluded enrolment of its multi-centre Phase II trial of fanregratinib (HMPL-453), a treatment for intrahepatic cholangiocarcinoma (IHCC) individuals…
News
Everest Medicines begins dosing in mRNA cancer vaccine trial
Tris Pharma eyes approval after pain drug triumphs in second Phase III trial
Beckley Psytech completes subjects’ enrolment for Phase IIb trial of TRD therapy
Neurocrine Biosciences initiates trial of VMAT2 inhibitor in healthy adults
Persica’s antibiotic-based drug alleviates lower back pain in Phase Ib trial
Abbott’s brain stimulation trial for depression kicks off at Mount Sinai
Suvoda introduces AI assistant to manage clinical trials
